Nimesulide inhibits crypt epithelial cell proliferation at 6 hours in the small intestine in CD-1 mice

Area of Science:

• Gastroenterology
• Pharmacology
• Cell Biology

Background:

• Cyclooxygenase-2 (COX-2) inhibitors are known for their improved gastrointestinal safety profile compared to nonselective NSAIDs.
• The mechanisms underlying this gut-sparing effect, particularly early crypt kinetic alterations, require further investigation.

Purpose of the Study:

• To compare the effects of a selective COX-2 inhibitor (nimesulide) and a nonselective COX inhibitor (indomethacin) on small intestinal mucosal epithelial cell proliferation and morphometry.
• To investigate whether early crypt kinetic mechanisms contribute to the gut-sparing selectivity of COX-2 inhibitors.

Main Methods:

• A comparative study using indomethacin (nonselective COX inhibitor) and nimesulide (selective COX-2 inhibitor) in an animal model.
• Assessment of small intestinal mucosal epithelial cell proliferation, crypt cell production rate, and morphometry.

Main Results:

• Both indomethacin and nimesulide reduced crypt cell proliferation in different segments of the small intestine.
• Indomethacin decreased proximal small intestine crypt cell production rate, while nimesulide reduced proliferation in both proximal and distal segments.
• A reduction in proliferating cell compartments was observed in mid-intestinal segments for both drug groups, suggesting altered crypt cell emigration.

Conclusions:

• Despite its COX-2 selectivity, nimesulide induced widespread initial effects on intestinal cell kinetics, comparable to the nonselective indomethacin.
• Early crypt kinetic mechanisms may not be the sole factor responsible for the gut-sparing selectivity observed with COX-2 inhibitors.